RecruitingNCT03094429
About this title
An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults
Read the official source — NCT03094429What is this study about?This study evaluates the safety and effectiveness of NaBen® for people with schizophrenia.
In PasadenaSchizophreniaMedication studyAges 18–55
- Countries
- United States
- Sponsor
- SyneuRx International (Taiwan) Corp
RecruitingACTRN12612000222842
Official study titlePregnant women in Indonesia, attending an Antenatal Resilience and Optimism Workshop, to reduce postnatal depression symptoms?
In IndonesiaDepressionInterventional studyAges 15–59
- Countries
- Indonesia
- Sponsor
- Curtin University
RecruitingNCT07691411
Official study titleCombining Machine Learning and Ecological Momentary Assessment of Depression, Cognitive Function and Daily Activity Behavior to Support Self-Management for Post-stroke Patients: A Feasibility Study
In Hong KongDepressionBehavioural studyAges 18+
- Countries
- China
- Sponsor
- The Hong Kong Polytechnic University
RecruitingACTRN12615000684527
Official study titleAn effect of antenatal and postnatal maternal support programs on mental health and mother-infant attachment in comparison to standard care in pregnant women at risk for mental illness: A Randomised Controlled Trial.
In ParkvillePersonality disorders, Schizophrenia, ...Interventional studyAges 18+
- Countries
- Australia
- Sponsor
- Professor Louise Newman